Fujifilm Holdings Corp. (TYO:4901) recently announced that it has developed software for 3D mapping of blood vessels for use in interventional radiology and other catheter surgical procedures. The system works in ways similar to car navigation systems, choosing a catheter route calculated to cause the least harm and discomfort to the patient. The software will...
Fujifilm
Fujifilm Creates Genome-Edited Epidermis Model, Replicates Changes Caused by Age
Fujifilm Holdings Corp. (TYO:4901) announced on March 23 that it has produced a 3D epidermis model from genome-edited human epidermal cells. The new model is capable of replicating age-related skin changes. As well as applying the new technology to the anti-aging skin care range that it plans to launch this autumn, Fujifilm intends to use...
Taki Chemical Uses Fish Collagen to Regenerate Cartilage
Taki Chemical Co. Ltd. (TYO:4025), in collaboration with J-TEC Co. Ltd. (TYO:7774), has developed a cartilage regeneration material using fish-derived collagen. Animal tests have confirmed that the material regenerates cartilage tissue and that the tissue is highly durable. This type of cartilage regeneration simply requires injection and could pave the way to new technologies that...
Fujifilm Helps Cut CO2 Emissions With Magnetic Data Storage Tape
Fujifilm Holdings Corp. (TYO:4901) is working to reduce CO2 emissions by spreading the use of a magnetic tape that has the world’s highest data storage capacity. Magnetic data storage tape consumes far less electrical energy than hard disc drive (HDD) storage devices, which must remain constantly powered up, resulting in commensurate reductions in CO2 emissions....
Fujifilm President Discusses Wako Acquisition, Prospectives Moving Forward
Fujifilm Holdings Corp. (TYO:4901) will buy Wako Pure Chemical Industries Ltd. this April for 154.7 billion yen ($1.36 billion) as part of a strategic expansion into the health care sector. In an interview with The Chemical Daily, the company’s president, Kenji Sukeno, explained that the acquisition is an important piece of a plan to rapidly...
Fujifilm Partners with Major Russian Pharmaceutical Firm
Fujifilm Holdings Corp. (TYO:4901) announced on Dec. 16 that it has agreed with Russian pharmaceuticals manufacturer R-Pharm to enter into a comprehensive business partnership. Established in 2001, Moscow-based R-Pharm operates across approximately 60 locations in Russia, generating sales of 77.6 billion rubles ($1.24 billion) in 2015. The company works together with Western pharmaceuticals firms on...
Fujifilm Announces Deal to Acquire Wako
Fujifilm Holdings Corp. (TYO:4901) announced on Dec. 15 that it will acquire major reagent manufacturer Wako Pure Chemical Industries Ltd., a subsidiary of Takeda Pharmaceutical Co. Ltd. (TYO:4502) for about 154.7 billion yen ($1.31 billion). Fujifilm aims to speed up the growth of its healthcare business through the acquisition of Wako, which is expected to...
Toyama Chemical Works on Drug Development for Facilitating Post-Stroke Rehabilitation
Fujifilm Group company Toyama Chemical Co. Ltd. is setting out to develop a drug to facilitate post-stroke rehabilitation, working together with Takuya Takahashi, professor of physiology at Yokohama City University’s Graduate School of Medicine. Toyama Chemical’s aim is to develop new applications for T-817MA, a low-molecular compound currently under development as a drug for treating...
NARO, NH Foods and Fujifilm Develop Detection Kit for Foot-and-Mouth Disease Virus
The National Agriculture and Food Research Organization (NARO), NH Foods Ltd. (TYO:2282) and Fujifilm Holdings Corp. (TYO:4901) are developing immunochromatography test kits and are looking into practical applications. The kits are able to detect by type all serotypes for foot-and-mouth disease virus (FMDV), a contagious livestock pathogen. FMDV is highly contagious and early detection is...
Teijin Film Solutions Aims to Ramp up PEN Film Business
Teijin Film Solutions Ltd. is looking to shore up its polyethylene naphthalate (PEN) film business, aiming to generate 10 billion yen ($91.84 million) in annual revenue from the business for fiscal 2019. The company plans to expand sales of PEN films for flexible printed circuits (FPC) for automobiles and displays as well as for linear...
NEDO Tests Infrastructure Inspection Robots in Kanagawa
The New Energy and Industrial Technology Development Organization (NEDO) is testing a dam survey robot system developed by QI Inc., Yokohama, and a bridge inspection robot developed by Fujifilm Holding Corp. (TYO:4901) in Kanagawa Prefecture. The process will be rapidly deployed to Japan’s infrastructure, such as to dams and bridges that were built 50 years...
Fujifilm to Invest in China’s Second Largest Pharmaceutical Company
Fujifilm Holdings Corp. (TYO:4901) will invest in China Resources Pharmaceutical Group Ltd., the second largest pharmaceutical company in China. Fujifilm has reached an agreement to subscribe for HK$820 million ($105.67 million) of ordinary shares in China Resources Pharmaceutical Group pursuant to its new listing on the Stock Exchange of Hong Kong (SEHK). China Resources Pharmaceutical...
Fujifilm Advances Development of Stem Cell-derived Regenerative Medicine
Fujifilm Holdings Corp. (TYO:4901) subsidiary Cellular Dynamics International Inc. (CDI) is advancing development of regenerative medical products derived from induced pluripotent stem cells (iPSCs) in the U.S. CDI plans by 2019 to commence clinical trials on regenerative medicine using iPSC for ophthalmic disorder, Parkinson’s disease and cardiac arrest. In a joint effort with the National...
Material Connexion Holds Japanese Material Exhibition in Tokyo
Material Connexion Inc., a U.S.-based materials consultancy that has developed a materials library on a global scale, is hosting an exhibition of Japanese materials in Tokyo through Material Connecxion Tokyo, the company’s branch in Minato-ku Ward, Tokyo. Running from Aug. 1 to Oct. 18, the exhibition is titled, “Japan Materials ~A Showcase of Incredible Japanese...
